Streptomycin sulphate microspheres: formulation and in vivo distribution

References

• Aronsen K. F., Hellekant C., Holmberg J., Rothman U., Teder H. Controlled blocking of hepatic artery flow with enzymatically degradable microspheres combined with oncolytic drugs. European Surgical Research 1979; 11: 99
   PubMed Web of Science ®Google Scholar
• Baker R. W., Tuttle M. E., Helwing R. Novel erodible polymers for the delivery of macromolecules. Pharmaceutical Technology 1984; 8: 26
   Google Scholar
• Dispensatory of the United States of America. Lippincott, Philadelphia 1960; 1321–1334
   Google Scholar
• Ercan M. T. Chromatographic quality control of 99mTc-labelled radiopharmaceuticals. Hacettepe Bulletin of Medicine / Surgery 1976; 9: 85
   Google Scholar
• Garrod L. P. Antibiotic and Chemotherapy. Churchill Livingstone, Edinburgh 1973; 102
   Google Scholar
• Guyton A. C. Textbook of Medical Physiology. Saunders, Philadelphia 1976; 386
   Google Scholar
• Hashida M., Muranishi S., Sezaki H., Tanigawa N., Satomura K., Hikasa Y. Increased lymphatic delivery of bleomycin by microsphere in oil emulsion and its effect on lymph node metastasis. International Journal of Pharmaceutics 1979; 2: 245
   Web of Science ®Google Scholar
• Hashida M., Takahashi Y., Muranishi S., Sezaki H. An application of water-in-oil and gelatin-microsphere-in-oil emulsions to specific delivery of anticancer agent into stomach lymphatics. Journal of Pharmacokinetics and Biopharmaceutics 1977; 5: 241
   PubMedGoogle Scholar
• Hashida M., Yashioka T., Muranishi S., Sezaki H. Dosage form characteristics of microsphere-in-oil emulsions. I. Stability and drug release. Chemical and Pharmaceutical Bulletin 1980; 28: 1009
   Web of Science ®Google Scholar
• Illum L., Davis S. S. The kinetics of uptake and organ deposition of colloidal drug carrier particles delivered to rabbits. Proceedings of the Second European Congress of Biopharmaceutics and Pharmacokinetics, Salamanca, 1984; Vol. II: 97–106
   Google Scholar
• Kanke M., Simmons G. H., Weiss D. L., Bivins B. A., Deluca P. P. Clearance of 141Ce-labeled microspheres from blood and distribution in specific organs following intravenous and intraarterial administration in beagle dogs. Journal of Pharmaceutical Sciences 1980; 69: 755
   PubMed Web of Science ®Google Scholar
• Kaymakcalan S., Kayaalp S. O., Kiran B. K. Tibbi Farmakoloji, Prensipler ve Kavramlar. Ankara Üniversitesi Basimevi, Ankara 1976; 684–687
   Google Scholar
• Lee T. K., Sokoloski T. D., Royer G. P. Serum albumin beads: an injectable, biodegradable system for the sustained release of drugs. Science 1981; 213: 233
   PubMed Web of Science ®Google Scholar
• Merck Index. Rahway Inc., New Jersey 1976; 564
   Google Scholar
• Nelson W. E., Forgacs J., Kucera J. L. Alteration of the distribution and excretion of streptomycin. Proceedings of the Society for Experimental Biology and Medicine 1947; 64: 20
   PubMedGoogle Scholar
• Nc B., Shaw S. M., Kessler W. V., Landolt R. R., Peck G. E., Dockerty G. H. Distribution and degradation of iodine-125 albumin microspheres and technetium-99m sulfur colloid. Canadian Journal of Pharmaceutical Sciences 1980; 15: 30
   Google Scholar
• Rhodes B. A., Wagner H. N., Jr. Improved lung scans using 99mTc-albumin microspheres. Nuclear Medicine 1969; 10: 432
   Google Scholar
• Rhodes B. A., Zolle I., Buchanan J. W., Wagner H. N., Jr. Radioactive albumin microspheres for studies of the pulmonary circulation. Nuclear Medicine 1969; 92: 1453
   Google Scholar
• Richards P., Atkins H. L. Technetium-99m Labelled Compounds 1967; 1, USAEC Rep. BNL-11831
   Google Scholar
• Russell G. F. J. Starch microspheres as drug delivery systems. Pharmacy International 1983; 4: 260
   Google Scholar
• Scheffel U., Rhodes B. A., Natarajan T. K., Wagner H. N., Jr. Albumin microspheres for study of the reticuloendothelial system. Journal of Nuclear Medicine 1972; 13: 498
   PubMed Web of Science ®Google Scholar
• Sugibayashi K., Akimoto M., Morimoto Y., Nadai T., Kato Y. Drugcarrier property of albumin microspheres in chemotherapy III. Effect of microsphereentrapped 5-fluorouracil on Ehrlich Ascites Carcinoma in mice. Journal of Pharmaceutical Dynamics 1979; 2: 350
   Google Scholar
• Sugibayashi K., Morimoto Y., Nadai T., Kato Y. Drug carrier property of albumin microspheres in chemotherapy. I. Tissues distribution of microsphereentrapped 5-fluorouracil in mice. Chemical and Pharmaceutical Bulletin 1977; 25: 3433
   PubMed Web of Science ®Google Scholar
• Tomlinson E. Microsphere delivery systems for drug targeting and controlled release. International Journal of Pharmaceutical Technology 1983; 4: 49
   Google Scholar
• Valentine F. C. O., Shooter R. A. Findlay's Recent Advances in Chemotherapy. Antibiotics. J. A. Churchill Ltd. 1954; Vol. III: 17–41
   Google Scholar
• Waksman S. A. Streptomycin: Background, isolation, properties, and utilization. Antibiotics and Chemotherapy 1953; 3: 333
   Google Scholar
• Waksman S. A., Schatz A. Streptomycin-origin, nature and properties. Journal of the American Pharmaceutical Association 1945; 34: 273
   Google Scholar
• Widder K., Flouret G., Senyei A. Magnetic microspheres: Synthesis of a novel parenteral drug carrier. Journal of Pharmaceutical Sciences 1979; 68: 79
   PubMed Web of Science ®Google Scholar
• Widder K. J., Senyei A. E., Ovadia H., Paterson P. Y. Specific cell binding using staphylococcal protein A magnetic microspheres. Journal of Pharmaceutical Sciences 1981; 70: 387
   PubMed Web of Science ®Google Scholar
• Widder K. J., Senyei A. E., Scarpelli D. G. Magnetic microspheres: A model system for site specific drug delivery in vivo. Proceedings of the Society for Experimental Biology and Medicine 1978; 58: 141
   Google Scholar
• Yoshioka T., Hashida M., Muranishi S., Sezaki H. Specific delivery of mitomycin C to the liver, spleen and lung: nano and microspherical carriers of gelatin. International Journal of Pharmaceutics 1981; 81: 131
   Google Scholar